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• Individuals with respiratory infections are often 
prescribed needless antibiotics and spend 
unnecessary time in the hospital1
• Diagnosis of a specific respiratory pathogen 
with polymerase chain reaction (PCR) testing 
can reduce costs and total length of stay (LOS) 
for patients with positive results2,3
• The goal of this study is to determine whether 
the results of PCR testing for respiratory 
pathogens impact antibiotic days of therapy 
(DOT), LOS, and cost at Lehigh Valley Health 
Network (LVHN)*
*Data taken from Muhlenberg and Cedar Crest hospitals.
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• A positive PCR test for respiratory viruses 
resulted in lower LOS, fewer DOT, and a 
reduction in fixed, variable, and total costs 
at LVHN
• A positive PCR test does not influence time 
spent in ICU care
• The targets most commonly identified 
through the comprehensive respiratory PCR 
testing were influenza a-matrix and 
rhinovirus/enterovirus 
• These findings suggest that prescribers may have 
reacted to the PCR test results in a way that led to the 
desired outcomes (shorter LOS, less antibiotic use, 
and decreased costs)
• An alternative explanation is that individuals with 
negative test results had illnesses that required more 
antibiotics use, longer hospitalization, and were more 
expensive to care for
• Limitations for this research included analyzing only a 
single year of data of the respiratory panel and did not 
evaluate which antibiotics were used
• Strengths for this research included the large sample 





THE IMPACT OF MULTIPLEX RESPIRATORY PATHOGEN PCR TESTING AT A LARGE ACADEMIC 
INSTITUTION
Hailey Reiss; Jarrod Kile, RPh; Eric Young, MD
Data for all patients who had the NxTAG® Respiratory Pathogen Panel (see 
Figure 1 for details) performed in 2019 at LVHN were obtained and the 
following information was reviewed.
Data relating to DOT, LOS, and cost were analyzed to find differences between 
the two groups regarding these variables.
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Table 1. Demographics
Positive Target Negative Target P-Value
Number of Patients 1547 3954 -
Number of Patients 
Receiving ICU Care
340 1289 -
Age (years) 67.51 (0-104) 68.01 (1-106) 0.19
Sex 0.02
Female 863 (55.8%) 2002 (50.6%) -
Male 684 (44.2%) 1952 (49.4%) -
Race 0.27
American Indian or 
Alaska Native
2 (0.1%) 3 (0.07%) -
Asian 17 (1%) 34 (0.9%) -
Black or African 
American
57 (4%) 223 (6%) -
Multi-racial 73 (5%) 132 (3%) -
Native Hawaiian or 
Other Pacific Islander
1 (0.06%) 2 (0.05%) -
Other 53 (3%) 121 (3%) -
Not Recorded 16 (1%) 61 (2%) -
White or Caucasian 1328 (86%) 3378 (85%) -
Influenza A-Matrix 359 - -
Rhinovirus or       
Enterovirus 
537 - -
Other Virus 651 - -
Figure 1. NxTAG® Respiratory Pathogen Panel Targets (US-IVD)4
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